Column - September 24, 2025
Trump’s tariffs might be the push that helps us go from resilience to antifragility
Many times in life, as in politics and business, bad events lead to painful change and, eventually, a better situation. While the Trump administration’s erratic tariff war has rattled the European life science industry, it might ultimately be the calamity that brings about a more resilient industry in the end.
Column - November 12, 2024
Navigating and rethinking the EU’s legislation labyrinth
The life science innovation gap between the EU and its global competitors continues to widen while the number of EU regulations affecting the industry is rising. Are we heading in the right direction?